Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: a national derivation and validation cohort study
Kelly Elimian(Karolinska Institutet), Chikwe Ihekweazu(Nigeria Centre for Disease Control), William Nwachukwu(Nigeria Centre for Disease Control), Babatunde Saka, Nwando Mba(Nigeria Centre for Disease Control), Oluwatosin Wuraola Akande(World Health Organization - Pakistan), Cornelius Ohonsi(Nigeria Centre for Disease Control), Adebola Olayinka(World Health Organization - Nigeria), Chinwe Lucia Ochu(Nigeria Centre for Disease Control), Shaibu Oricha Bello(Usmanu Danfodiyo University), Anastacia Okwudili Ojimba(Federal Medical Centre), Chidiebere Ezeokafor(National Agency for the Control of AIDS), Olanrewaju Falodun(National Hospital Abuja), Arisekola Jinadu(Nigeria Centre for Disease Control), Tochi Okwor(Nigeria Centre for Disease Control), Khadeejah Liman Hamza(Ahmadu Bello University), Jafiya Abubakar(Nigeria Centre for Disease Control), Tobias Alfvén(Karolinska Institutet), John Oladejo(Nigeria Centre for Disease Control), Ehimario Igumbor(University of the Western Cape), Habib Garba Zaiyad(University of Abuja Teaching Hospital), Ismail Abdus-Salam, Carina King(Karolinska Institutet), Giulia Gaudenzi(Karolinska Institutet), Olaolu Aderinola(Nigeria Centre for Disease Control), Puja Myles(University of Nottingham), Chinedu Arinze(Nigeria Centre for Disease Control), Chioma Dan-Nwafor(Nigeria Centre for Disease Control), Abimbola Bowale, Emmanuel Joseph(Kaduna State University), Jack Gibson(University of Crete), John Tunde Aremu(Gombe State University), Michael C. Asuzu(University College Hospital, Ibadan), Christian C. Ibeh(Nnamdi Azikiwe University Teaching Hospital), Bamidele Mutiu, Blessing Ebhodaghe(Nigeria Centre for Disease Control), Elsie Ilori(Nigeria Centre for Disease Control)
Cited by 6
Related Papers
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
|European Respiratory Journal|1995|1.6k
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
|The Lancet Global Health|2019|642
The Lancet Nigeria Commission: investing in health and the future of the nation
|The Lancet|2022|346
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
|American Journal of Obstetrics and Gynecology|2021|310